Siu Wong
Cardiovascular Disease · S El Monte, CANPI 1114082518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AstraZeneca at 41.1% of the total.
Across 110 payments — averaging $29.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$498
- Boehringer Ingelheim$336
- Amarin Pharma, Inc.$326
- AbbVie$170
- Vanda Pharmaceuticals Inc.$165
- plus $420 from 10 others
What the payments were for
- Food & beverage$3,23299%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $1,339 |
| Amgen | 16 | $498 |
| Boehringer Ingelheim | 10 | $336 |
| Amarin Pharma, Inc. | 12 | $326 |
| AbbVie(2 entities) | 9 | $170 |
| Vanda Pharmaceuticals Inc. | 8 | $165 |
| Lilly USA, LLC | 5 | $100 |
| Scilex Pharmaceuticals Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Merck | 3 | $57 |
| Gilead | 1 | $28 |
| UCB, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,255 in reported general payments places this provider in the 55th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in S El Monte
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.